TetraLogic Pharmaceuticals Corporation (TLOG)

TLOG Statistics

Total Valuation

TetraLogic Pharmaceuticals has a market cap or net worth of 24.

Market Cap	24
Enterprise Value	n/a

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

TetraLogic Pharmaceuticals has 24.32 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	24.32M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	0.02%
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.48

Current Ratio	0.48
Quick Ratio	0.44
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	-1.29
Interest Coverage	-3.13

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-19.59%
Return on Capital (ROIC)	-73.83%
Revenue Per Employee	n/a
Profits Per Employee	-1.36M
Employee Count	30
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	3.30
52-Week Price Change	n/a
50-Day Moving Average	n/a
200-Day Moving Average	n/a
Relative Strength Index (RSI)	33.92
Average Volume (20 Days)	6,427

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	0.02

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-21.29M
Pretax Income	-43.04M
Net Income	-40.72M
EBITDA	-21.14M
EBIT	-21.29M
Earnings Per Share (EPS)	-1.65

Balance Sheet

The company has 5.89 million in cash and 30.83 million in debt, giving a net cash position of -24.95 million or -1.03 per share.

Cash & Cash Equivalents	5.89M
Total Debt	30.83M
Net Cash	-24.95M
Net Cash Per Share	-1.03
Equity (Book Value)	-30.94M
Book Value Per Share	-1.25
Working Capital	-6.96M

Cash Flow

In the last 12 months, operating cash flow was -23.88 million and capital expenditures -666, giving a free cash flow of -23.88 million.

Operating Cash Flow	-23.88M
Capital Expenditures	-666
Free Cash Flow	-23.88M
FCF Per Share	-0.98

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

TetraLogic Pharmaceuticals does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-7.35%
Shareholder Yield	-7.35%
Earnings Yield	-169,660,237.50%
FCF Yield	-99,508,091.67%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a